Carregant...
Update in the medical therapy of Cushing’s disease
PURPOSE OF REVIEW: Recently developed agents treat Cushing’s disease by inhibiting adrenocorticotropic hormone (ACTH) secretion from corticotrope tumors or antagonizing cortisol action. RECENT FINDINGS: The dopamine agonist cabergoline and the somatostatin agonist pasireotide target ACTH secretion....
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4215263/ https://ncbi.nlm.nih.gov/pubmed/23807605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MED.0b013e3283631809 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|